Clinical Trial: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB598 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
Brief Summary:
The primary purpose of this study is to assess the safety and tolerability of AB598 when taken alone, and in combination with zimberelimab and standard chemotherapy in participants with advanced malignancies.
Read more